Symbols / ITRM $0.03 Iterum Therapeutics PLC
ITRM Chart
Stock Fundamentals
|
|
|
|
|
|
About
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Ratings
Current target
$0.03
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-30 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2024-08-15 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-06-21 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-31 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-14 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-04-30 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-04-01 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-03-06 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-02-07 | up | HC Wainwright & Co. | Neutral → Buy | $6 |
- Iterum Therapeutics plc (NASDAQ:ITRM): Are Analysts Optimistic? - Yahoo Finance Wed, 01 Apr 2026 07
- Iterum moves toward liquidation as ORLYNVAH faces possible U.S. exit - Stock Titan Fri, 27 Mar 2026 07
- Iterum Therapeutics plc Announces Petition for Winding Up and Appointment of Joint Provisional Liquidators - Quiver Quantitative Fri, 27 Mar 2026 07
- Top 3 Penny Stocks Exploding Today — ITRM, BFRG, RDGT (Most Active) (LeclKZ7AhR) - Fathom Journal Fri, 24 Apr 2026 00
- Breakeven On The Horizon For Iterum Therapeutics plc (NASDAQ:ITRM) - simplywall.st Wed, 01 Apr 2026 07
- Iterum seeks court-led dissolution amid cash crisis, inability to raise funds - Reuters Fri, 27 Mar 2026 07
- Top pre-market gainers today — ELAB, ITRM, LTRN among stocks soaring before the bell - MSN hu, 23 Apr 2026 11
- Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Plummets on Wider-Than-Expected Q3 Loss - ChartMill Fri, 14 Nov 2025 08
- Why Is Iterum Therapeutics Stock (ITRM) Down Today? - TipRanks ue, 03 Mar 2026 08
- Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit - The Globe and Mail Sat, 28 Mar 2026 07
- Iterum Therapeutics (NASDAQ: ITRM) faces Nasdaq delisting and winding up - Stock Titan ue, 31 Mar 2026 07
- Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long - Yahoo Finance Fri, 17 Oct 2025 07
- ITERUM THERAPEUTICS Earnings Preview: Recent $ITRM Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Wed, 12 Nov 2025 08
- Iterum Therapeutics (NASDAQ: ITRM) seeks court-backed wind up - Stock Titan Fri, 27 Mar 2026 07
- New PBM deal could open ORLYNVAH access to 40M more people in 2026 - Stock Titan Wed, 17 Dec 2025 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Cost Of Revenue |
|
0.25
|
0.00
|
0.00
|
—
|
| Reconciled Cost Of Revenue |
|
0.25
|
0.00
|
0.00
|
—
|
| Gross Profit |
|
-0.25
|
0.00
|
0.00
|
—
|
| Operating Expense |
|
18.44
-61.15%
|
47.47
+56.23%
|
30.38
+23.83%
|
24.54
|
| Research And Development |
|
10.46
-73.85%
|
39.99
+127.01%
|
17.62
+64.46%
|
10.71
|
| Selling General And Administration |
|
7.98
+6.80%
|
7.48
-41.44%
|
12.77
-7.66%
|
13.82
|
| General And Administrative Expense |
|
7.98
+6.80%
|
7.48
-41.44%
|
12.77
-7.66%
|
13.82
|
| Salaries And Wages |
|
3.19
-11.94%
|
3.62
-41.20%
|
6.15
+26.34%
|
4.87
|
| Other Gand A |
|
4.80
+24.36%
|
3.86
-41.66%
|
6.61
-26.15%
|
8.96
|
| Total Expenses |
|
18.70
-60.61%
|
47.47
+56.23%
|
30.38
+23.83%
|
24.54
|
| Operating Income |
|
-18.70
+60.61%
|
-47.47
-56.23%
|
-30.38
-23.83%
|
-24.54
|
| Total Operating Income As Reported |
|
-18.70
+60.61%
|
-47.47
-56.23%
|
-30.38
-23.83%
|
-24.54
|
| EBITDA |
|
-21.73
+37.17%
|
-34.58
+13.49%
|
-39.97
+51.96%
|
-83.20
|
| Normalized EBITDA |
|
-18.46
+59.55%
|
-45.64
-0.45%
|
-45.43
-104.29%
|
-22.24
|
| Reconciled Depreciation |
|
0.28
-83.77%
|
1.75
-2.78%
|
1.80
-14.45%
|
2.10
|
| EBIT |
|
-22.01
+39.41%
|
-36.33
+13.03%
|
-41.77
+51.03%
|
-85.31
|
| Total Unusual Items |
|
-3.27
-129.57%
|
11.06
+102.57%
|
5.46
+108.95%
|
-60.96
|
| Total Unusual Items Excluding Goodwill |
|
-3.27
-129.57%
|
11.06
+102.57%
|
5.46
+108.95%
|
-60.96
|
| Special Income Charges |
|
—
|
—
|
0.00
|
0.00
|
| Net Income |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Pretax Income |
|
-24.53
+35.02%
|
-37.76
+14.44%
|
-44.13
+51.43%
|
-90.86
|
| Net Non Operating Interest Income Expense |
|
-2.52
-76.61%
|
-1.43
+39.52%
|
-2.36
+57.48%
|
-5.55
|
| Interest Expense Non Operating |
|
2.52
+76.61%
|
1.43
-39.52%
|
2.36
-57.48%
|
5.55
|
| Net Interest Income |
|
-2.52
-76.61%
|
-1.43
+39.52%
|
-2.36
+57.48%
|
-5.55
|
| Interest Expense |
|
2.52
+76.61%
|
1.43
-39.52%
|
2.36
-57.48%
|
5.55
|
| Other Income Expense |
|
-3.32
-129.77%
|
11.14
+197.80%
|
-11.39
+81.26%
|
-60.77
|
| Other Non Operating Income Expenses |
|
-0.05
-157.32%
|
0.08
+100.49%
|
-16.85
-8739.49%
|
0.20
|
| Gain On Sale Of Security |
|
-3.27
-129.57%
|
11.06
+102.57%
|
5.46
+108.95%
|
-60.96
|
| Tax Provision |
|
0.24
-60.85%
|
0.61
+103.65%
|
0.30
-57.30%
|
0.70
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.41
-129.57%
|
1.38
+102.57%
|
0.68
+108.95%
|
-7.62
|
| Net Income Including Noncontrolling Interests |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Net Income From Continuing Operation Net Minority Interest |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Net Income From Continuing And Discontinued Operation |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Net Income Continuous Operations |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Normalized Income |
|
-21.91
+54.39%
|
-48.05
+2.37%
|
-49.21
-28.75%
|
-38.22
|
| Net Income Common Stockholders |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Diluted EPS |
|
-1.26
+53.83%
|
-2.73
+18.46%
|
-3.35
+56.79%
|
-7.74
|
| Basic EPS |
|
-1.26
+53.83%
|
-2.73
+18.46%
|
-3.35
+56.79%
|
-7.74
|
| Basic Average Shares |
|
19.70
+40.11%
|
14.06
+5.93%
|
13.27
+12.35%
|
11.81
|
| Diluted Average Shares |
|
19.70
+40.11%
|
14.06
+5.93%
|
13.27
+12.35%
|
11.81
|
| Diluted NI Availto Com Stockholders |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
44.59
+69.83%
|
26.26
-60.71%
|
66.83
-26.97%
|
91.51
|
| Current Assets |
|
24.79
-3.16%
|
25.60
-59.01%
|
62.44
-25.01%
|
83.27
|
| Cash Cash Equivalents And Short Term Investments |
|
24.12
+0.81%
|
23.93
-60.64%
|
60.80
-25.28%
|
81.38
|
| Cash And Cash Equivalents |
|
24.12
+297.38%
|
6.07
-71.22%
|
21.09
-23.15%
|
27.45
|
| Other Short Term Investments |
|
0.00
-100.00%
|
17.86
-55.03%
|
39.71
-26.37%
|
53.94
|
| Receivables |
|
0.07
-71.67%
|
0.23
-44.52%
|
0.42
-65.15%
|
1.21
|
| Taxes Receivable |
|
0.07
-71.67%
|
0.23
-44.52%
|
0.42
-54.10%
|
0.92
|
| Accrued Interest Receivable |
|
—
|
—
|
0.06
-81.03%
|
0.29
|
| Prepaid Assets |
|
0.53
-62.94%
|
1.43
+17.46%
|
1.22
+79.41%
|
0.68
|
| Restricted Cash |
|
—
|
—
|
—
|
0.00
|
| Other Current Assets |
|
0.07
|
—
|
—
|
—
|
| Total Non Current Assets |
|
19.81
+2887.63%
|
0.66
-84.89%
|
4.39
-46.75%
|
8.24
|
| Net PPE |
|
0.02
-54.90%
|
0.05
-26.09%
|
0.07
-24.18%
|
0.09
|
| Gross PPE |
|
0.36
-0.82%
|
0.37
+3.68%
|
0.35
-6.37%
|
0.38
|
| Accumulated Depreciation |
|
-0.34
-7.94%
|
-0.32
-10.92%
|
-0.28
+0.70%
|
-0.29
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.21
-1.38%
|
0.22
+6.34%
|
0.20
+43.36%
|
0.14
|
| Other Properties |
|
—
|
—
|
—
|
0.09
|
| Leases |
|
0.15
+0.00%
|
0.15
+0.00%
|
0.15
+0.00%
|
0.15
|
| Goodwill And Other Intangible Assets |
|
19.75
|
0.00
-100.00%
|
1.72
-49.96%
|
3.44
|
| Other Non Current Assets |
|
0.04
-93.63%
|
0.61
-76.47%
|
2.60
-44.86%
|
4.72
|
| Total Liabilities Net Minority Interest |
|
48.68
+49.03%
|
32.66
-15.89%
|
38.83
-5.91%
|
41.27
|
| Current Liabilities |
|
17.61
+30.23%
|
13.52
+49.14%
|
9.06
-29.96%
|
12.94
|
| Payables And Accrued Expenses |
|
2.90
-77.25%
|
12.76
+79.17%
|
7.12
+214.49%
|
2.26
|
| Payables |
|
0.25
-94.98%
|
5.00
+80.10%
|
2.77
+152.41%
|
1.10
|
| Accounts Payable |
|
0.25
-94.98%
|
5.00
+80.10%
|
2.77
+215.95%
|
0.88
|
| Current Accrued Expenses |
|
2.65
-65.84%
|
7.76
+78.58%
|
4.35
+273.05%
|
1.17
|
| Total Tax Payable |
|
—
|
—
|
0.00
-100.00%
|
0.22
|
| Income Tax Payable |
|
—
|
—
|
0.00
-100.00%
|
0.22
|
| Current Debt And Capital Lease Obligation |
|
14.46
|
—
|
—
|
1.63
|
| Current Debt |
|
14.46
|
—
|
—
|
1.63
|
| Other Current Borrowings |
|
14.46
|
—
|
—
|
1.63
|
| Other Current Liabilities |
|
0.24
-68.46%
|
0.76
-60.85%
|
1.94
-78.52%
|
9.05
|
| Total Non Current Liabilities Net Minority Interest |
|
31.07
+62.30%
|
19.14
-35.69%
|
29.77
+5.07%
|
28.33
|
| Long Term Debt And Capital Lease Obligation |
|
31.07
+63.91%
|
18.96
-33.41%
|
28.47
+14.33%
|
24.90
|
| Long Term Debt |
|
31.07
+63.91%
|
18.96
-33.41%
|
28.47
+14.33%
|
24.90
|
| Other Non Current Liabilities |
|
—
|
0.19
-85.58%
|
1.30
-62.05%
|
3.44
|
| Stockholders Equity |
|
-4.08
+36.26%
|
-6.40
-122.87%
|
28.00
-44.26%
|
50.23
|
| Common Stock Equity |
|
-4.08
+36.26%
|
-6.40
-122.87%
|
28.00
-44.26%
|
50.23
|
| Capital Stock |
|
0.32
+133.33%
|
0.14
+7.14%
|
0.13
+3.28%
|
0.12
|
| Common Stock |
|
0.32
+133.33%
|
0.14
+7.14%
|
0.13
+3.28%
|
0.12
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
31.53
+115.37%
|
14.64
+7.15%
|
13.67
+3.39%
|
13.22
|
| Ordinary Shares Number |
|
31.53
+115.37%
|
14.64
+7.15%
|
13.67
+3.39%
|
13.22
|
| Additional Paid In Capital |
|
481.68
+5.92%
|
454.76
+0.80%
|
451.15
+5.26%
|
428.61
|
| Retained Earnings |
|
-486.07
-5.37%
|
-461.30
-9.07%
|
-422.93
-11.74%
|
-378.49
|
| Gains Losses Not Affecting Retained Earnings |
|
0.00
-100.00%
|
0.00
+100.29%
|
-0.35
|
0.00
|
| Other Equity Adjustments |
|
—
|
0.00
+100.29%
|
-0.35
|
—
|
| Total Equity Gross Minority Interest |
|
-4.08
+36.26%
|
-6.40
-122.87%
|
28.00
-44.26%
|
50.23
|
| Total Capitalization |
|
26.99
+115.01%
|
12.55
-77.77%
|
56.47
-24.85%
|
75.13
|
| Working Capital |
|
7.18
-40.54%
|
12.08
-77.37%
|
53.38
-24.10%
|
70.33
|
| Invested Capital |
|
41.45
+230.22%
|
12.55
-77.77%
|
56.47
-26.44%
|
76.76
|
| Total Debt |
|
45.53
+140.21%
|
18.96
-33.41%
|
28.47
+7.32%
|
26.52
|
| Net Debt |
|
21.41
+66.15%
|
12.88
+74.74%
|
7.37
|
—
|
| Net Tangible Assets |
|
-23.83
-272.12%
|
-6.40
-124.36%
|
26.28
-43.84%
|
46.80
|
| Tangible Book Value |
|
-23.83
-272.12%
|
-6.40
-124.36%
|
26.28
-43.84%
|
46.80
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-26.77
+31.93%
|
-39.33
-112.91%
|
-18.47
-16.61%
|
-15.84
|
| Cash Flow From Continuing Operating Activities |
|
-26.77
+31.93%
|
-39.33
-112.91%
|
-18.47
-16.61%
|
-15.84
|
| Net Income From Continuing Operations |
|
-24.77
+35.44%
|
-38.37
+13.64%
|
-44.43
+51.47%
|
-91.56
|
| Depreciation Amortization Depletion |
|
0.28
-83.77%
|
1.75
-2.78%
|
1.80
-14.45%
|
2.10
|
| Depreciation |
|
0.03
-3.23%
|
0.03
-63.10%
|
0.08
-78.52%
|
0.39
|
| Amortization Cash Flow |
|
0.25
-85.22%
|
1.72
+0.17%
|
1.72
+0.18%
|
1.71
|
| Depreciation And Amortization |
|
0.28
-83.77%
|
1.75
-2.78%
|
1.80
-14.45%
|
2.10
|
| Amortization Of Intangibles |
|
0.25
-85.22%
|
1.72
+0.17%
|
1.72
+0.18%
|
1.71
|
| Other Non Cash Items |
|
7.17
+20.62%
|
5.95
+10.44%
|
5.38
-33.86%
|
8.14
|
| Stock Based Compensation |
|
0.36
-53.70%
|
0.78
-96.45%
|
22.11
+411.88%
|
4.32
|
| Operating Gains Losses |
|
3.27
+129.57%
|
-11.06
-102.57%
|
-5.46
-108.95%
|
60.96
|
| Gain Loss On Investment Securities |
|
3.27
+129.57%
|
-11.06
-102.57%
|
-5.46
-108.95%
|
60.96
|
| Change In Working Capital |
|
-12.73
-560.77%
|
2.76
+19.56%
|
2.31
+625.23%
|
-0.44
|
| Change In Prepaid Assets |
|
-2.66
+16.47%
|
-3.19
-105.54%
|
-1.55
-253.87%
|
1.01
|
| Change In Payables And Accrued Expense |
|
-9.86
-272.53%
|
5.71
+12.44%
|
5.08
+948.08%
|
-0.60
|
| Change In Accrued Expense |
|
-5.11
-246.46%
|
3.49
+9.54%
|
3.19
+581.12%
|
-0.66
|
| Change In Payable |
|
-4.75
-313.45%
|
2.22
+17.31%
|
1.90
+2907.94%
|
0.06
|
| Change In Account Payable |
|
-4.75
-313.45%
|
2.22
+17.31%
|
1.90
+2907.94%
|
0.06
|
| Change In Other Working Capital |
|
0.15
-42.80%
|
0.27
+153.14%
|
-0.51
-288.19%
|
0.27
|
| Change In Other Current Assets |
|
0.02
-94.72%
|
0.32
|
0.00
+100.00%
|
-0.01
|
| Change In Other Current Liabilities |
|
-0.39
-8.76%
|
-0.35
+50.00%
|
-0.71
+36.33%
|
-1.11
|
| Investing Cash Flow |
|
18.21
-21.97%
|
23.34
+67.20%
|
13.96
+125.56%
|
-54.59
|
| Cash Flow From Continuing Investing Activities |
|
18.21
-21.97%
|
23.34
+67.20%
|
13.96
+125.56%
|
-54.59
|
| Net PPE Purchase And Sale |
|
-0.00
+84.62%
|
-0.01
+79.03%
|
-0.06
-1.64%
|
-0.06
|
| Purchase Of PPE |
|
-0.00
+84.62%
|
-0.01
+79.03%
|
-0.06
-1.64%
|
-0.06
|
| Capital Expenditure |
|
-0.00
+84.62%
|
-0.01
+79.03%
|
-0.06
-1.64%
|
-0.06
|
| Net Investment Purchase And Sale |
|
18.21
-22.01%
|
23.35
+66.55%
|
14.02
+125.71%
|
-54.53
|
| Purchase Of Investment |
|
-12.39
+69.91%
|
-41.18
+9.91%
|
-45.71
+31.81%
|
-67.03
|
| Sale Of Investment |
|
30.60
-52.58%
|
64.53
+8.04%
|
59.73
+377.82%
|
12.50
|
| Financing Cash Flow |
|
26.69
+2481.33%
|
1.03
+156.88%
|
-1.82
-102.19%
|
83.13
|
| Cash Flow From Continuing Financing Activities |
|
26.69
+2481.33%
|
1.03
+156.88%
|
-1.82
-102.19%
|
83.13
|
| Net Issuance Payments Of Debt |
|
0.00
|
0.00
+100.00%
|
-2.25
+65.45%
|
-6.52
|
| Issuance Of Debt |
|
—
|
—
|
0.00
|
0.00
|
| Repayment Of Debt |
|
0.00
|
0.00
+100.00%
|
-2.25
+65.45%
|
-6.52
|
| Long Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
0.00
|
0.00
+100.00%
|
-2.25
+65.45%
|
-6.52
|
| Net Long Term Debt Issuance |
|
0.00
|
0.00
+100.00%
|
-2.25
+65.45%
|
-6.52
|
| Net Common Stock Issuance |
|
26.69
+2481.33%
|
1.03
+138.80%
|
0.43
-99.52%
|
89.64
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Changes In Cash |
|
18.13
+221.18%
|
-14.96
-136.19%
|
-6.33
-149.91%
|
12.69
|
| Effect Of Exchange Rate Changes |
|
-0.07
-22.95%
|
-0.06
-22.00%
|
-0.05
-1350.00%
|
0.00
|
| Beginning Cash Position |
|
6.11
-71.10%
|
21.13
-23.21%
|
27.51
+85.68%
|
14.82
|
| End Cash Position |
|
24.16
+295.72%
|
6.11
-71.10%
|
21.13
-23.21%
|
27.51
|
| Free Cash Flow |
|
-26.77
+31.95%
|
-39.34
-112.26%
|
-18.54
-16.55%
|
-15.90
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
-100.00%
|
0.02
-94.71%
|
0.42
|
| Income Tax Paid Supplemental Data |
|
0.22
-45.14%
|
0.40
-51.16%
|
0.82
+88.74%
|
0.43
|
| Amortization Of Securities |
|
-0.35
+69.26%
|
-1.15
-525.68%
|
-0.18
-128.77%
|
0.64
|
| Common Stock Issuance |
|
26.69
+2481.33%
|
1.03
+138.80%
|
0.43
-99.52%
|
89.64
|
| Issuance Of Capital Stock |
|
26.69
+2481.33%
|
1.03
+138.80%
|
0.43
-99.52%
|
89.64
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|